Complete vs Sanchez Research Lab

Please see Uses and Important Safety Information including BOXED WARNING for RINVOQ (upadacitinib) at www.rinvoq.com/important-safety-information. Please see Uses and Important Safety Information for SKYRIZI (risankizumab-rzaa) at www.skyrizi.com/important-safety-information. Please see the Full Prescribing Information for RINVOQ at www.rxabbvie.com/pdf/rinvoq_pi.pdf and SKYRIZI at www.rxabbvie.com/pdf/skyrizi_pi.pdf. The Complete App features personalized treatment logging, symptom logging, and medication reminders to support and encourage you throughout treatment. CUSTOMIZED INJECTION LOGGING & TRAINING FOR SKYRIZI PATIENTS · Keep track of when and where you inject SKYRIZI on your body. · View your injection history by date with details. Tap on a specific date to see injection times, sites, and notes. · Personalize how you rotate injection sites in a chronological order. · Use in-app videos, training kits, and more to review injection training from your doctor. DOSE TRACKING FOR RINVOQ PATIENTS · Make it easier to stick to your treatment plan and track treatment with the RINVOQ dose tracker. DOSE REMINDERS & MEDICATION TRACKERS · Tools to help manage your medication through this free app. Set reminders and enable push notifications so you never miss a dose. CALENDAR · View your treatment schedule, symptom history, and a body diagram of injection locations. SYMPTOM TRACKING · Keep a log of your symptoms to discuss at your next doctor visit. This may help you have more productive discussions about your treatment. ACCESS MORE COMPLETE RESOURCES · Request resources to support you throughout treatment, like a Savings Card that may help eligible patients lower prescription cost†. · Connect with an Ambassador*, there to provide support and help answer questions. · Submit receipts for reimbursement on eligible out-of-pocket expenses through the Complete Prescription Rebate†. †Please see the Savings Card Terms & Conditions for RINVOQ at www.rinvoq.com/resources/save-on-rinvoq-costs#saving-cards-t-m and SKYRIZI at https://www.skyrizi.com/skyrizi-complete/save-on-skyrizi-costs#tandcs. *Ambassadors are provided by AbbVie and do not work under the direction of your health care professional (HCP) or give medical advice. They are trained to direct patients to their HCP for treatment-related advice, including further referrals. Additional Information If you’re taking SKYRIZI or RINVOQ, you may want help starting and staying on track with your treatment plan. The Complete App can help by providing resources that allow you to set reminders, track symptoms, and create personal goals that can support and encourage you throughout your treatment journey. If you have any questions or concerns with the Complete App, or you need to report medication side effects or adverse events, call 1.866.SKYRIZI (1.866.759.7494) for SKYRIZI and 1-800-2RINVOQ (1-800-274-6867) for RINVOQ. This app is intended for the exclusive use of U.S. residents 18 years of age and older. The Complete App is not intended to provide treatment decisions or replace the care and advice of a licensed healthcare provider. All medical analysis and treatment plans should be performed by a licensed healthcare provider. US-MULT-260568

• Sexual and gender minorities (SGMs, sometimes denoted LGBTQ+) have disproportionately high rates of depression, suicidal ideation, substance use, and physical health problems. Previous research has posited “minority stress” as the primary cause of SGM health disparities, but exposure to minority stressors (such as discrimination, denigration, and victimization) does not consistently predict physical health issues in SGM populations, thus suggesting that our understanding of the health effects of stigma remains incomplete. To fill in that gap, we have designed this app in conjunction with our research study to investigate SGM perceived inclusion and safety. • This app contains a questionnaire that consists of 43 questions. Of these, 20 questions have answers of “Yes” or “No”, six have a multiple-choice answer, 16 questions are on a Likert scale, and one question requires a short answer. Questions are meant to measure the person’s emotional state in their current location by asking about the environment, the other people there, and the user’s feelings about those things. • Only enrolled study participants will be provided with a login to access the application. For more details on this research study and to potentially receive access to app features, please visit: • This app collects survey responses and the user’s background location while logged in. This location is tracked as part of the research study to verify that users are in their reported location when they respond to the survey. This permission is required for survey use, but location tracking is disabled when the user signs out.